Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug
Open Access
- 1 June 2012
- journal article
- review article
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 34, S104-S117
Abstract
To review and describe studies of the non-psychotomimetic constituent of Cannabis sativa, cannabidiol (CBD), as an anxiolytic drug and discuss its possible mechanisms of action. The articles selected for the review were identified through searches in English, Portuguese, and Spanish in the electronic databases ISI Web of Knowledge, SciELO, PubMed, and PsycINFO, combining the search terms "cannabidiol and anxiolytic", "cannabidiol and anxiolytic-like", and "cannabidiol and anxiety". The reference lists of the publications included, review articles, and book chapters were handsearched for additional references. Experimental animal and human studies were included, with no time restraints. Studies using animal models of anxiety and involving healthy volunteers clearly suggest an anxiolytic-like effect of CBD. Moreover, CBD was shown to reduce anxiety in patients with social anxiety disorder. Future clinical trials involving patients with different anxiety disorders are warranted, especially of panic disorder, obsessive-compulsive disorder, social anxiety disorder, and post-traumatic stress disorders. The adequate therapeutic window of CBD and the precise mechanisms involved in its anxiolytic action remain to be determined.Keywords
This publication has 31 references indexed in Scilit:
- Cannabis and anxiety: a critical review of the evidenceHuman Psychopharmacology: Clinical and Experimental, 2009
- 5‐HT1Areceptors are involved in the cannabidiol‐induced attenuation of behavioural and cardiovascular responses to acute restraint stress in ratsBritish Journal of Pharmacology, 2008
- Cannabidiol – Recent AdvancesChemistry & Biodiversity, 2007
- Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in ratsBehavioural Brain Research, 2006
- Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drugBrazilian Journal of Medical and Biological Research, 2006
- Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoidsBehavioural Pharmacology, 2005
- Antianxiety effect of cannabidiol in the elevated plus-mazePsychopharmacology, 1990
- Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjectsPsychopharmacology, 1982
- Chemical Basis of Hashish ActivityScience, 1970
- Marihuana ChemistryScience, 1970